GEN Exclusives

More »

GEN News Highlights

More »
May 20, 2009

Lab21 Acquires Plasmatec Subsidiary from Axis-Shield

  • Lab21 acquired U.K.-based in vitro diagnostics manufacturer and distributor, Plasmatec Laboratory Products, from Axis-Shield.  Plasmatec sells a comprehensive range of diagnostic tests in regions including Europe, Central and South America, Africa, the Middle East, and Asia Pacific.

    “This is a great acquisition for Lab21. Plasmatec is a highly successful business and gives further critical mass to our diagnostic products division. This acquisition follows the purchase earlier this year of Biotec Laboratories and underlines the momentum of our buy-and-build strategy,” explains Graham Mullis, CEO of Lab21.

    Ian Gilham, Axis-Shield CEO, says the company felt Lab21 was better placed to further develop the Plasmatec business model. “This divestment reflects our increasing focus on high margin diagnostic technologies and markets and our investment in state-of-the-art testing at point-of-care.”

     


    ♦♦♦
    Related News

    Lab21 Acquires Biotec Laboratories to Expand Diagnostic Focus (Mar. 3, 2009)



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?